LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 97 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.57 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $128,492 | -55.0% | 117,883 | -5.4% | 0.00% | – |
| Q2 2023 | $285,256 | +20.7% | 124,566 | +28.1% | 0.00% | – |
| Q1 2023 | $236,388 | +24.7% | 97,279 | -2.0% | 0.00% | – |
| Q4 2022 | $189,546 | -17.9% | 99,239 | +3.3% | 0.00% | – |
| Q3 2022 | $231,000 | +53.0% | 96,060 | +18.3% | 0.00% | – |
| Q2 2022 | $151,000 | -8.5% | 81,225 | +3.2% | 0.00% | – |
| Q1 2022 | $165,000 | -51.2% | 78,726 | -8.3% | 0.00% | – |
| Q4 2021 | $338,000 | -16.3% | 85,888 | +2.4% | 0.00% | -100.0% |
| Q3 2021 | $404,000 | -6.3% | 83,888 | -10.6% | 0.00% | 0.0% |
| Q2 2021 | $431,000 | -2.0% | 93,834 | +25.1% | 0.00% | 0.0% |
| Q1 2021 | $440,000 | +99.1% | 75,010 | +16.0% | 0.00% | – |
| Q4 2020 | $221,000 | +137.6% | 64,639 | 0.0% | 0.00% | – |
| Q3 2020 | $93,000 | -27.9% | 64,639 | 0.0% | 0.00% | – |
| Q2 2020 | $129,000 | +2.4% | 64,639 | 0.0% | 0.00% | – |
| Q1 2020 | $126,000 | -52.5% | 64,639 | +1.2% | 0.00% | – |
| Q4 2019 | $265,000 | +38.0% | 63,900 | 0.0% | 0.00% | – |
| Q3 2019 | $192,000 | -52.2% | 63,900 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $402,000 | +6.9% | 63,900 | -5.5% | 0.00% | 0.0% |
| Q1 2019 | $376,000 | -16.3% | 67,634 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $449,000 | -36.8% | 67,634 | +1.6% | 0.00% | 0.0% |
| Q3 2018 | $710,000 | -10.6% | 66,570 | +0.7% | 0.00% | -50.0% |
| Q2 2018 | $794,000 | +41.3% | 66,133 | +0.8% | 0.00% | +100.0% |
| Q1 2018 | $562,000 | -16.2% | 65,628 | -3.4% | 0.00% | 0.0% |
| Q4 2017 | $671,000 | -21.0% | 67,929 | -1.7% | 0.00% | -50.0% |
| Q3 2017 | $849,000 | -32.4% | 69,102 | -9.5% | 0.00% | -33.3% |
| Q2 2017 | $1,256,000 | +5.3% | 76,335 | -8.3% | 0.00% | +50.0% |
| Q1 2017 | $1,193,000 | -1.0% | 83,227 | -4.5% | 0.00% | 0.0% |
| Q4 2016 | $1,205,000 | -25.4% | 87,127 | -2.6% | 0.00% | -33.3% |
| Q3 2016 | $1,616,000 | +27.0% | 89,427 | +0.9% | 0.00% | 0.0% |
| Q2 2016 | $1,272,000 | +20.9% | 88,627 | +0.7% | 0.00% | +50.0% |
| Q1 2016 | $1,052,000 | +2.7% | 88,025 | +14.4% | 0.00% | 0.0% |
| Q4 2015 | $1,024,000 | +26.1% | 76,947 | +1.8% | 0.00% | 0.0% |
| Q3 2015 | $812,000 | +32.9% | 75,575 | -0.4% | 0.00% | +100.0% |
| Q2 2015 | $611,000 | – | 75,875 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
| BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
| Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
| NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
| PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
| XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
| WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |